In fact, BRAF-mutated NAMPT over-expressing MM cells are strikingly similar to cells that have acquired resistance to BRAFi in terms of growth, invasion and phenotype plasticity, including mesenchymal and stem properties. This evidence concerns the gene BRAF and Miyoshi myopathy.